Back
Automatically translated version. May contain inaccuracies compared to the original.
The story of Tryfonova M.D. and the “miracle drug” Biopatid is becoming increasingly interesting.
This is reported by “Vikryvach.”
Owner of the clinic Maria Tryfonova is under guard with a bail of 68 million UAH. Anatoliy Cherkassky, whom the media, citing law enforcement, names as one of the scheme’s organizers, is also in custody, with bail of 75 million UAH. Both are suspects; the court must make final determinations.
Now the detail: Anatoliy Cherkassky previously headed LLC “Tryfonova MD,” was among the founders, and an application for the BIOPATID trademark was filed in his name. Public records show he is the father of Ruslan Cherkassky — the former deputy head of the State Customs Service. Maria Tryfonova is Ruslan’s cohabitant.
A kind of family startup: a clinic, the customs service, and a drug of unknown origin.
Biopatid is not registered in Ukraine as a medicinal product. According to the investigation, terzepatide was imported from China, declared as a dietary supplement, and then in an underground laboratory dispensed into vials and sold as an injectable drug.
The cost of materials is about $17. The sale price is up to $1200. In June 2026 of the year, according to court testimony, more than 4 thousand vials were produced. The total volume of production since the start of the year is estimated by the investigation at more than $5 million.
This is margin.
In the case there are already 27 suspects and more than 250 searches. And this is not a fake handbag. These are injections that were administered to people.
Back in January 2026 year, the State Pharmacological Service stated that BIOPATID is not registered in Ukraine, and one of the series was found to be counterfeit and forbidden for sale and use.
Another thread of the story is Ruslan Cherkassky. NABU and SAP are investigating possible illegal enrichment and money laundering of over 60 million UAH. The materials mention premium real estate, luxury cars, and a clinic space for Tryfonova.
Now the main question: how did a substance of unknown origin pass through customs, transform into an injectable drug, be marketed through a well-known clinic, and be sold for millions?
For such a “business,” one laboratory is not enough.
It is necessary that several doors in the state system be very conveniently opened at once.
Who exactly held them open — this is what the investigators and the court are now to determine.
Document: PDF proof of the original version of the news item "Мільйони на одному флаконі Biopatid: як Трифонова та близькі колишнього митника Черкаського зробили з китайського тирзепатиду прибутковий багатомільйо...". It records the publication content at the moment of the first scan, the preservation date and the source: Rozsliduvach.
